. The event brought together policy makers, investors, solution providers, and business leaders to help turbocharge the transition to net zero emissions.
The other highlight was the presentation from the CEO of AstraZeneca, who explained how the climate crisis is also a health crisis because of increased air pollution from fossil fuels. This crisis is driving the pharmaceutical industry to target decarbonizing their operations by 2035. As the pharmaceutical industry works towards this goal, it will certainly help the global healthcare industry move in a similar direction.
There is a drive to have ESG metrics baked into the DNA of organizations’ IT systems to ensure visibility of supplier and environmental risk. For example, if your business is dependent on water, and you have two suppliers. One has a fantastic Water Assessment Program, the other doesn't. This level of detail can be lost in the complexity of a spreadsheet, which could result in a failure to cite the risk one of your suppliers pose on financial statements.
There is huge benefit to looking at systemic industry issues in collaboration with other key players in the industry. Ultimately, we all benefit from a supply chain that is responsible, efficient, and clean and it will take collective effort to accelerate these changes.Elena: The first thing that organizations can do is talk to their technology implementation partners to better understand how they can start embedding ESG metrics into the systems that run their business.